Early Study of Brain-Permeable BRAF Inhibitor Shows Positive Results - AJMC.com Managed Markets Network

Brain metastasis from melanoma is particularly deadly and options are limited due to the difficulty of breaching the brain-blood barrier.

Recent research illustrated the potent and prolonged antitumor activity of a BRAF inhibitor, C1a, that can cross the blood-brain barrier to attack brain metastases from malignant melanoma. Brain met… [+2805 chars]

full article...